Trade COAG anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Hemab Therapeutics Holdings, Inc. (COAG) is trading at US$48.43, down 2.14% today as of Aug 28, 10:31 EDT. The company has a market capitalisation of US$2.3B. Over the past 52 weeks, COAG has traded between US$23.00 and US$55.42. On Syfe you can trade COAG with $0 commission and add it to your watchlist.
| Previous close | US$49.49 |
|---|---|
| Market cap | US$2.3B |
| 52-week range | US$23.00 – US$55.42 |
| Volume | 354.96K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded on February 12, 2026 and is headquartered in Cambridge, MA.
Year: 2026
Hemab Therapeutics' Sutacimig Continues to Support Durable Bleed Reduction, Wedbush Says
Jul 14, 2:50 PM · MT Newswires
Sector Update: Healthcare Stocks Advance Late Afternoon
Jul 13, 7:34 PM · MT Newswires
Hemab Therapeutics Holdings, Inc. (COAG) stock is trading at US$48.43, -2.14% from the previous close of US$49.49.
The market cap for Hemab Therapeutics Holdings, Inc. (COAG) stock is approximately US$2.3B.
The 52-week high for Hemab Therapeutics Holdings, Inc. (COAG) stock is US$55.42.
The 52-week low for Hemab Therapeutics Holdings, Inc. (COAG) stock is US$23.00.
Hemab Therapeutics Holdings, Inc. (COAG) does not currently pay a dividend.
Stay on top of COAG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
